Pregnancy outcomes in women with liver disease: Is pregnancy safe? A cross-sectional study

Background: There is evidence suggesting that the pregnancy outcome may be affected by some medical conditions, such as liver diseases. Objective: The present study aimed to investigate the prevalence of liver disease and its outcomes in pregnant women referred to antenatal clinic in the hospital. M...

Full description

Saved in:
Bibliographic Details
Main Authors: Reza Shekarriz-Foumani (Author), Fakhrolmolouk Yassaee (Author), Sara Tarokh (Author), Mahbobeh Taheri (Author)
Format: Book
Published: Shahid Sadoughi University of Medical Sciences, 2020-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8fc00ee8f1aa4bd4a8e3e4513d773dc9
042 |a dc 
100 1 0 |a Reza Shekarriz-Foumani  |e author 
700 1 0 |a Fakhrolmolouk Yassaee  |e author 
700 1 0 |a Sara Tarokh  |e author 
700 1 0 |a Mahbobeh Taheri  |e author 
245 0 0 |a Pregnancy outcomes in women with liver disease: Is pregnancy safe? A cross-sectional study 
260 |b Shahid Sadoughi University of Medical Sciences,   |c 2020-10-01T00:00:00Z. 
500 |a 2476-3772 
500 |a 10.18502/ijrm.v13i10.7774 
520 |a Background: There is evidence suggesting that the pregnancy outcome may be affected by some medical conditions, such as liver diseases. Objective: The present study aimed to investigate the prevalence of liver disease and its outcomes in pregnant women referred to antenatal clinic in the hospital. Materials and Methods: In this cross-sectional study, all pregnant women with abnormal liver function test attending antenatal clinic affiliated to Shahid Beheshti University of Medical Sciences were recruited from August 2017 to July 2018. All participants were followed-up until delivery with respect to the maternal and neonatal outcome. Results: Of a total of 7,121 pregnant women recruited in the study, 110 (1.58%) women were detected with a liver disease; of these, 105 women were diagnosed with pregnancy-specific liver diseases, including HELLP syndrome (10.9%), preeclampsia (50.98%), partial HELLP (0.9%), eclampsia (0.9%), acute fatty liver (9.1%), intra-hepatic cholestasis 25 (22.7%), and 5 women the non-pregnancy-specific liver disease, including Liver transplantation (2.7%), and Autoimmune hepatitis (1.8%). Prevalence of the premature birth was 64.5% in pregnancy-specific liver disease, but no premature birth was detected in cases with liver transplantation. We found that neonatal mortality was significantly associated with neonatal prematurity (p = 0.013), IUGR (p < 0.001), placental pathology (p = 0.04), we had no maternal mortality. Conclusion: Liver disease is not uncommon in pregnancy. This study demonstrated that pregnancy is safe in women with liver disease. 
546 |a EN 
690 |a liver diseases, maternal, outcome, neonatal, pregnancy. 
690 |a Gynecology and obstetrics 
690 |a RG1-991 
690 |a Reproduction 
690 |a QH471-489 
655 7 |a article  |2 local 
786 0 |n International Journal of Reproductive BioMedicine, Vol 18, Pp 899-904 (2020) 
787 0 |n https://doi.org/10.18502/ijrm.v13i10.7774 
787 0 |n https://doaj.org/toc/2476-3772 
856 4 1 |u https://doaj.org/article/8fc00ee8f1aa4bd4a8e3e4513d773dc9  |z Connect to this object online.